Ciprofloxacin controlled release - Labopharm

Drug Profile

Ciprofloxacin controlled release - Labopharm

Alternative Names: Ciprofloxacin implant - Labopharm; Controlled-release ciprofloxacin implant - Labopharm

Latest Information Update: 28 Apr 2008

Price : $50

At a glance

  • Originator Labopharm
  • Class Antibacterials; Cyclopropanes; Fluoroquinolones; Piperazines; Small molecules
  • Mechanism of Action Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Bone and joint infections

Most Recent Events

  • 30 Oct 2003 Labopharm's controlled-release ciprofloxacin implant is available for licensing (http://labopharm.com)
  • 30 Oct 2003 Preclinical trials in Bone and joint infections in Canada (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top